PerkinElmer acquires Spectral Genomics

PerkinElmer, Inc. (Shelton, Connecticut) announced the acquisition of Spectral Genomics, Inc. (Houston, Texas), a leading company in molecular karyotyping technology used to evaluate chromosomal abnormalities.

PerkinElmer, Inc. (Shelton, Connecticut) announced the acquisition of Spectral Genomics, Inc. (Houston, Texas), a leading company in molecular karyotyping technology used to evaluate chromosomal abnormalities.

Spectral Genomics? array products and analysis software help pharmaceutical, biotechnology, cytogenetic, and clinical researchers identify chromosomal abnormalities related to the study of cancer and pre- and post-natal genetic disorders. The company?s proprietary Array CGH provides high-resolution global views of the human genome, enabling researchers to identify the exact location of any chromosomal deletions and amplifications that can cause an increased risk of genetic disease.